Your browser doesn't support javascript.
loading
Lifestyle changes in middle age and risk of cancer: evidence from the European Prospective Investigation into Cancer and Nutrition.
Botteri, Edoardo; Peveri, Giulia; Berstad, Paula; Bagnardi, Vincenzo; Hoff, Geir; Heath, Alicia K; Cross, Amanda J; Vineis, Paolo; Dossus, Laure; Johansson, Mattias; Freisling, Heinz; Matta, Komodo; Huybrechts, Inge; Chen, Sairah L F; B Borch, Kristin; Sandanger, Torkjel M; H Nøst, Therese; Dahm, Christina C; Antoniussen, Christian S; Tin Tin, Sandar; Fournier, Agnès; Marques, Chloé; Artaud, Fanny; Sánchez, Maria-José; Guevara, Marcela; Santiuste, Carmen; Agudo, Antonio; Bajracharya, Rashmita; Katzke, Verena; Ricceri, Fulvio; Agnoli, Claudia; Bergmann, Manuela M; Schulze, Matthias B; Panico, Salvatore; Masala, Giovanna; Tjønneland, Anne; Olsen, Anja; Stocks, Tanja; Manjer, Jonas; Aizpurua-Atxega, Amaia; Weiderpass, Elisabete; Riboli, Elio; Gunter, Marc J; Ferrari, Pietro.
Afiliação
  • Botteri E; Department of Research, Cancer Registry of Norway, Oslo, Norway.
  • Peveri G; Section for Colorectal Cancer Screening, Cancer Registry of Norway, Oslo, Norway.
  • Berstad P; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
  • Bagnardi V; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Hoff G; Section for Colorectal Cancer Screening, Cancer Registry of Norway, Oslo, Norway.
  • Heath AK; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
  • Cross AJ; Section for Colorectal Cancer Screening, Cancer Registry of Norway, Oslo, Norway.
  • Vineis P; Department of Research, Telemark Hospital, Skien, Norway.
  • Dossus L; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Johansson M; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Freisling H; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Matta K; International Agency for Research On Cancer (IARC-WHO), World Health Organization, 25, Avenue Tony Garnier, CS 90627, 69366, Lyon Cedex 07, France.
  • Huybrechts I; International Agency for Research On Cancer (IARC-WHO), World Health Organization, 25, Avenue Tony Garnier, CS 90627, 69366, Lyon Cedex 07, France.
  • Chen SLF; International Agency for Research On Cancer (IARC-WHO), World Health Organization, 25, Avenue Tony Garnier, CS 90627, 69366, Lyon Cedex 07, France.
  • B Borch K; International Agency for Research On Cancer (IARC-WHO), World Health Organization, 25, Avenue Tony Garnier, CS 90627, 69366, Lyon Cedex 07, France.
  • Sandanger TM; International Agency for Research On Cancer (IARC-WHO), World Health Organization, 25, Avenue Tony Garnier, CS 90627, 69366, Lyon Cedex 07, France.
  • H Nøst T; Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
  • Dahm CC; Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
  • Antoniussen CS; Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
  • Tin Tin S; Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
  • Fournier A; HUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing , NTNU - Norwegian University of Science and Technology , Trondheim, Norway.
  • Marques C; Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Artaud F; Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Sánchez MJ; Cancer Epidemiology Unit, Oxford Population Health, University of Oxford, Oxford, UK.
  • Guevara M; Université Paris-Saclay, UVSQ, Inserm "Exposome, Heredity, Cancer and Health" Team, CESP U1018, Gustave Roussy, Villejuif, France.
  • Santiuste C; Université Paris-Saclay, UVSQ, Inserm "Exposome, Heredity, Cancer and Health" Team, CESP U1018, Gustave Roussy, Villejuif, France.
  • Agudo A; Université Paris-Saclay, UVSQ, Inserm "Exposome, Heredity, Cancer and Health" Team, CESP U1018, Gustave Roussy, Villejuif, France.
  • Bajracharya R; Escuela Andaluza de Salud Pública (EASP), Granada, Spain.
  • Katzke V; Instituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain.
  • Ricceri F; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Agnoli C; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.
  • Bergmann MM; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Schulze MB; Instituto de Salud Pública y Laboral de Navarra, 31003, Pamplona, Spain.
  • Panico S; Navarre Institute for Health Research (IdiSNA), 31008, Pamplona, Spain.
  • Masala G; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Tjønneland A; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
  • Olsen A; Unit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, L'Hospitalet de Llobregat, Spain.
  • Stocks T; Nutrition and Cancer Group; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet de Llobregat, Spain.
  • Manjer J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Aizpurua-Atxega A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Weiderpass E; Department of Clinical and Biological Sciences, Centre for Biostatistics, Epidemiology, and Public Health, University of Turin, Turin, Italy.
  • Riboli E; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy.
  • Gunter MJ; German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Ferrari P; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Eur J Epidemiol ; 39(2): 147-159, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38180593
ABSTRACT
In this study, we aimed to provide novel evidence on the impact of changing lifestyle habits on cancer risk. In the EPIC cohort, 295,865 middle-aged participants returned a lifestyle questionnaire at baseline and during follow-up. At both timepoints, we calculated a healthy lifestyle index (HLI) score based on cigarette smoking, alcohol consumption, body mass index and physical activity. HLI ranged from 0 (most unfavourable) to 16 (most favourable). We estimated the association between HLI change and risk of lifestyle-related cancers-including cancer of the breast, lung, colorectum, stomach, liver, cervix, oesophagus, bladder, and others-using Cox regression models. We reported hazard ratios (HR) with 95% confidence intervals (CI). Median time between the two questionnaires was 5.7 years, median age at follow-up questionnaire was 59 years. After the follow-up questionnaire, we observed 14,933 lifestyle-related cancers over a median follow-up of 7.8 years. Each unit increase in the HLI score was associated with 4% lower risk of lifestyle-related cancers (HR 0.96; 95%CI 0.95-0.97). Among participants in the top HLI third at baseline (HLI > 11), those in the bottom third at follow-up (HLI ≤ 9) had 21% higher risk of lifestyle-related cancers (HR 1.21; 95%CI 1.07-1.37) than those remaining in the top third. Among participants in the bottom HLI third at baseline, those in the top third at follow-up had 25% lower risk of lifestyle-related cancers (HR 0.75; 95%CI 0.65-0.86) than those remaining in the bottom third. These results indicate that lifestyle changes in middle age may have a significant impact on cancer risk.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estilo de Vida / Neoplasias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estilo de Vida / Neoplasias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article